MarketCap
Facebook
X
TelegramPRA Health Sciences, Inc. Current Ratio 2011-2026 | PRAH
Annual Current Ratio PRA Health Sciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 1.15 | 0.969 | 0.87 | 0.903 | 1.11 | 1.08 | 1.05 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.15 | 0.87 | 1.02 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
5.26 | $ 19.14 | 6.75 % | $ 201 M |  China |
 |
Agilent Technologies
A
|
2.01 | $ 121.35 | 3.28 % | $ 36.9 B |  USA |
 |
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M |  Israel |
 |
Aspira Women's Health
AWH
|
0.44 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
3.75 | $ 17.47 | 3.81 % | $ 931 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M |  Britain |
 |
Medpace Holdings
MEDP
|
1.3 | $ 517.83 | 3.31 % | $ 14.9 B | USA |
 |
Exact Sciences Corporation
EXAS
|
1.69 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Myriad Genetics
MYGN
|
2.09 | $ 4.78 | 4.03 % | $ 443 M | USA |
 |
NeoGenomics
NEO
|
2.6 | $ 8.24 | 3.0 % | $ 1.06 B | USA |
 |
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
6.01 | $ 1.44 | -0.69 % | $ 1.92 M | USA |
 |
Natera
NTRA
|
2.02 | $ 211.2 | 4.61 % | $ 20.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.69 | $ 29.12 | 2.0 % | $ 20 B |  Niderland |
 |
Castle Biosciences
CSTL
|
7.05 | $ 24.62 | 4.63 % | $ 684 M | USA |
 |
Senseonics Holdings
SENS
|
1.94 | $ 6.79 | 1.04 % | $ 283 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | China |
 |
Soleno Therapeutics
SLNO
|
4.96 | $ 52.65 | 0.01 % | $ 2.68 B | USA |
 |
Charles River Laboratories International
CRL
|
1.82 | $ 181.01 | 1.5 % | $ 8.97 B | USA |
 |
Interpace Biosciences
IDXG
|
2.95 | $ 2.2 | - | $ 9.73 M | USA |
 |
Danaher Corporation
DHR
|
5.19 | $ 199.23 | 1.72 % | $ 142 B | USA |
 |
Thermo Fisher Scientific
TMO
|
1.92 | $ 527.08 | 2.5 % | $ 199 B | USA |
 |
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
6.69 | $ 130.01 | 2.4 % | $ 20.7 B | USA |
 |
Twist Bioscience Corporation
TWST
|
3.8 | $ 56.04 | 11.22 % | $ 3.35 B | USA |
 |
Fulgent Genetics
FLGT
|
13.4 | $ 15.81 | 3.33 % | $ 478 M | USA |
 |
Guardant Health
GH
|
0.953 | $ 85.9 | 4.49 % | $ 10.8 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
7.55 | $ 2.86 | 0.35 % | $ 92.8 K | USA |
 |
Biomerica
BMRA
|
3.23 | $ 2.04 | -1.92 % | $ 4.69 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.29 | $ 112.83 | 2.23 % | $ 9.31 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 266.69 | 0.95 % | $ 22.2 B | USA |
 |
Waters Corporation
WAT
|
2.02 | $ 332.64 | 2.45 % | $ 19.8 B | USA |
 |
Celcuity
CELC
|
1.27 | $ 119.92 | -0.4 % | $ 5.61 B | USA |
 |
Neogen Corporation
NEOG
|
2.51 | $ 9.51 | 3.99 % | $ 2.06 B | USA |
 |
Lantheus Holdings
LNTH
|
1.96 | $ 83.23 | 1.91 % | $ 5.62 B | USA |
 |
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | Israel |
 |
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.25 | $ 193.17 | 0.13 % | $ 21.4 B | USA |